Biodegradable Polymer-Based Drug-Delivery Systems for Ocular Diseases
International Journal of Molecular Sciences · 19.08.2023 · 24 (16) · 12976
DOI: 10.3390/ijms241612976 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.08.2023. Verfasst von Ta-Hsin Tsung und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Tri-Service General Hospital, National Defense Medical Center, Taipei 11490, Taiwan. Hauptthemen laut MEDLINE: Eye, Glaucoma. Die Arbeit wurde bisher 143-mal zitiert (Crossref) und nennt 242 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tri-Service General Hospital, National Defense Medical Center, Tri-Service General Hospital Research Foundation.
Abstract (Originalsprache)
Ocular drug delivery is a challenging field due to the unique anatomical and physiological barriers of the eye. Biodegradable polymers have emerged as promising tools for efficient and controlled drug delivery in ocular diseases. This review provides an overview of biodegradable polymer-based drug-delivery systems for ocular diseases with emphasis on the potential for biodegradable polymers to overcome the limitations of conventional methods, allowing for sustained drug release, improved bioavailability, and targeted therapy. Natural and synthetic polymers are both discussed, highlighting their biodegradability and biocompatibility. Various formulation strategies, such as nanoparticles, hydrogels, and microemulsions, among others, are investigated, detailing preparation methods, drug encapsulation, and clinical applications. The focus is on anterior and posterior segment drug delivery, covering glaucoma, corneal disorders, ocular inflammation, retinal diseases, age-related macular degeneration, and diabetic retinopathy. Safety considerations, such as biocompatibility evaluations, in vivo toxicity studies, and clinical safety, are addressed. Future perspectives encompass advancements, regulatory considerations, and clinical translation challenges. In conclusion, biodegradable polymers offer potential for efficient and targeted ocular drug delivery, improving therapeutic outcomes while reducing side effects. Further research is needed to optimize formulation strategies and address regulatory requirements for successful clinical implementation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Tri-Service General Hospital, National Defense Medical Center, Taipei 11490, Taiwan.
- Department of Ophthalmology, Taoyuan Armed Forces General Hospital, Taoyuan 325, Taiwan.
ORCID-Profile: Ta-Hsin Tsung
Förderung
- Tri-Service General Hospital
- National Defense Medical Center
- Tri-Service General Hospital Research Foundation
- National Defense Medical Center Foundation
Zitieren
APA
Tsung, T. H., Tsai, Y. C., Lee, H. P., Chen, Y. H., & Lu, D. W. (2023). Biodegradable Polymer-Based Drug-Delivery Systems for Ocular Diseases. International Journal of Molecular Sciences, 24(16), 12976. https://doi.org/10.3390/ijms241612976
Vancouver
Tsung TH, Tsai YC, Lee HP, Chen YH, Lu DW. Biodegradable Polymer-Based Drug-Delivery Systems for Ocular Diseases. International Journal of Molecular Sciences. 2023;24(16):12976. doi:10.3390/ijms241612976
BibTeX
@article{Tsung2023,
author = {Tsung, Ta-Hsin and Tsai, Yu-Chien and Lee, Hsin-Pei and Chen, Yi-Hao and Lu, Da-Wen},
title = {Biodegradable Polymer-Based Drug-Delivery Systems for Ocular Diseases},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {16},
pages = {12976},
doi = {10.3390/ijms241612976}
}
EUVIMED